VTVT has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
VTVT has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.
vTv Therapeutics's operating assets for the quarter that ended in Sep. 2024 was $1.59 Mil. vTv Therapeutics's operating liabilities for the quarter that ended in Sep. 2024 was $25.04 Mil. vTv Therapeutics's Total Assets for the quarter that ended in Jun. 2024 was $46.46 Mil. Therefore, vTv Therapeutics's scaled net operating assets (SNOA) for the quarter that ended in Sep. 2024 was -0.50.
The historical data trend for vTv Therapeutics's Scaled Net Operating Assets can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
vTv Therapeutics Annual Data | |||||||||||||||||||||
Trend | Dec14 | Dec15 | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | |||||||||||
Scaled Net Operating Assets | Get a 7-Day Free Trial |
![]() |
![]() |
-0.41 | -0.11 | 0.19 | -0.22 | -0.83 |
vTv Therapeutics Quarterly Data | ||||||||||||||||||||
Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | Jun24 | Sep24 | |
Scaled Net Operating Assets | Get a 7-Day Free Trial |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
-0.98 | -1.84 | -2.36 | -0.46 | -0.51 |
For the Biotechnology subindustry, vTv Therapeutics's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Biotechnology industry and Healthcare sector, vTv Therapeutics's Scaled Net Operating Assets distribution charts can be found below:
* The bar in red indicates where vTv Therapeutics's Scaled Net Operating Assets falls into.
Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.
vTv Therapeutics's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2023 is calculated as
Scaled Net Operating Assets (SNOA) | (A: Dec. 2023 ) | ||||
= | (Operating Assets (A: Dec. 2023 ) | - | Operating Liabilities (A: Dec. 2023 )) | / | Total Assets (A: Dec. 2022 ) |
= | (1.572 | - | 29.038) | / | 33.238 |
= | -0.83 |
where
Operating Assets | (A: Dec. 2023 ) | ||
= | Total Assets | - | Cash, Cash Equivalents, Marketable Securities |
= | 11.018 | - | 9.446 |
= | 1.572 |
Operating Liabilities | (A: Dec. 2023 ) | ||||
= | Total Liabilities | - | Long-Term Debt & Capital Lease Obligation | - | Short-Term Debt & Capital Lease Obligation |
= | 29.567 | - | 0.169 | - | 0.36 |
= | 29.038 |
vTv Therapeutics's Scaled Net Operating Assets (SNOA) for the quarter that ended in Sep. 2024 is calculated as
Scaled Net Operating Assets (SNOA) | (Q: Sep. 2024 ) | ||||
= | (Operating Assets (Q: Sep. 2024 ) | - | Operating Liabilities (Q: Sep. 2024 )) | / | Total Assets (Q: Jun. 2024 ) |
= | (1.593 | - | 25.038) | / | 46.458 |
= | -0.50 |
where
Operating Assets | (Q: Sep. 2024 ) | ||
= | Total Assets | - | Cash, Cash Equivalents, Marketable Securities |
= | 43.164 | - | 41.571 |
= | 1.593 |
Operating Liabilities | (Q: Sep. 2024 ) | ||||
= | Total Liabilities | - | Long-Term Debt & Capital Lease Obligation | - | Short-Term Debt & Capital Lease Obligation |
= | 25.251 | - | 0.032 | - | 0.181 |
= | 25.038 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Thank you for viewing the detailed overview of vTv Therapeutics's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.
Paul J Sekhri | director, officer: President and CEO | C/O VEEVA SYSTEMS INC., 4637 CHABOT DRIVE, SUITE 210, PLEASANTON CA 94588 |
Steven L. Tuch | officer: Chief Financial Officer | C/O VTV THERAPEUTICS INC., 3980 PREMIER DRIVE, HIGH POINT NC 27265 |
John A Fry | director | C/O DELAWARE INVESTMENTS, 2005 MARKET ST. 34TH FL., PHILADELPHIA PA 19103 |
Jonathan Isaacsohn | director | C/O VTV THERAPEUTICS INC., 3980 PREMIER DRIVE, HIGH POINT NC 27265 |
Fahed Al-marzooqi | director | AL KHATEM TOWER, ABU DHABI GLOBAL MARKET, ABU DHABI C0 00000 |
Keith R. Harris | director | C/O MEIRAGTX - US, 430 EAST 29TH STREET, 10TH FLOOR, NEW YORK NY 10016 |
Hersh Kozlov | director | WOLF BLOCK SCHORR & SOLIS, 1940 RTE 70 E, CHERRY HILL NJ 08003 |
Howard L. Weiner | director | 4170 MENDENHALL OAKS PKWY, HIGH POINT NC 27265 |
Chandresh Harjivan | director | C/O VTV THERAPEUTICS INC., 3980 PREMIER DRIVE, HIGH POINT NC 27265 |
Al-nahyan Tahnoon Bin Zayed S. | 10 percent owner | OFFICE 2458, FLOOR 24, AL-SILA TOWER, ABU DHABI C0 00000 |
G42 Investments Ai Holdings Rsc Ltd. | director, 10 percent owner | OFFICE 801, FLOOR 8, AL KHATEM TOWER, ABU DHABI C0 00000 |
Barry K. Brown | officer: Chief Accounting Officer | C/O VTV THERAPEUTICS INC., 3980 PREMIER DRIVE, HIGH POINT NC 27265 |
Rich S. Nelson | director, officer: Acting Chief Executive Officer | C/O VTV THERAPEUTICS INC., 3980 PREMIER DRIVE, HIGH POINT NC 27265 |
Ronald O Perelman | 10 percent owner | 35 EAST 62ND STREET, NEW YORK NY 10021 |
Deepa Prasad | director, officer: President and CEO | C/O VTV THERAPEUTICS INC., 3980 PREMIER DRIVE, SUITE 310, HIGH POINT NC 27265 |
From GuruFocus
By Marketwired • 11-01-2023
By Marketwired • 05-09-2024
By sperokesalga sperokesalga • 05-24-2023
By PRNewswire • 02-22-2024
By sperokesalga sperokesalga • 06-16-2023
By Marketwired • 11-12-2024
By PRNewswire • 03-19-2024
By PurpleRose PurpleRose • 07-27-2022
By Marketwired • 08-08-2024
By GuruFocus News • 11-13-2024
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.